3. Kumar NM, Gilula NB (1996) The gap junction communication channel. Cell 84: 381–388. 4. Cascio M, Kumar NM, Safarik R, Gilula NB (1995) Physical characterization of gap junction membrane connexons (hemi-channels) isolated from rat liver. J Biol Chem 270: 18643–18648. 5. Milks LC, Kumar NM, Houghten R, Unwin N, Gilula NB (1988) Topology of the 32-kd liver gap junction protein determined by site-directed antibody localizations. EMBO J 7: 2967–2975. 6. Eiberger J, Degen J, Romualdi A, Deutsch U, Willecke K, et al. (2001) Connexin genes in the mouse and human genome. Cell Commun Adhes 8: 163–165. 7. Gerido DA, White TW (2004) Connexin disorders of the ear, skin, and lens. Biochim Biophys Acta 1662: 159–170. 8. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, et al. (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262: 2039–2042. 9. Sosinsky GE, Nicholson BJ (2005) Structural organization of gap junction channels. Biochim Biophys Acta 1711: 99–125. 10. Unger VM, Kumar NM, Gilula NB, Yeager M (1999) Three-dimensional structure of a recombinant gap junction membrane channel. Science 283: 1176–1180. 11. Fleishman SJ, Unger VM, Yeager M, Ben Tal N (2004) A Calpha model for the transmembrane alpha helices of gap junction intercellular channels. Mol Cell 15: 879–888. 12. Oshima A, Tani K, Hiroaki Y, Fujiyoshi Y, Sosinsky GE (2007) Three- dimensional structure of a human connexin26 gap junction channel reveals a plug in the vestibule. Proc Natl Acad Sci U S A 104: 10034–10039. 13. Skerrett IM, Aronowitz J, Shin JH, Cymes G, Kasperek E, et al. (2002) Identification of amino acid residues lining the pore of a gap junction channel. J Cell Biol 159: 349–360. 14. Zhou XW, Pfahnl A, Werner R, Hudder A, Llanes A, et al. (1997) Identification of a pore lining segment in gap junction hemichannels. Biophys J 72: 1946–1953. 15. Kronengold J, Trexler EB, Bukauskas FF, Bargiello TA, Verselis VK (2003) Pore-lining residues identified by single channel SCAM studies in Cx46 hemichannels. Cell Commun Adhes 10: 193–199. 16. Kronengold J, Trexler EB, Bukauskas FF, Bargiello TA, Verselis VK (2003) Single-channel SCAM identifies pore-lining residues in the first extracellular loop and first transmembrane domains of Cx46 hemichannels. J Gen Physiol 122: 389–405. 17. Bicego M, Beltramello M, Melchionda S, Carella M, Piazza V, et al. (2006) Pathogenetic role of the deafness-related M34T mutation of Cx26. Hum Mol Genet 15: 2569–2587. 18. Hernandez VH, Bortolozzi M, Pertegato V, Beltramello M, Giarin MF, et al. (2007) Unitary permeability of gap junction channels to second messengers measured by FRET microscopy. Nat Methods 4: 353–358. 19. Guidoni L, Torre V, Carloni P (1999) Potassium and sodium binding to the outer mouth of the K+ channel. Biochemistry 38: 8599–8604. 20. Faraldo-Gomez JD, Forrest LR, Baaden M, Bond PJ, Domene C, et al. (2004) Conformational sampling and dynamics of membrane proteins from 10- nanosecond computer simulations. Proteins 57: 783–791. 21. Gong XQ, Nicholson BJ (2001) Size selectivity between gap junction channels composed of different connexins. Cell Commun Adhes 8: 187–192. 22. Bicego M, Morassutto S, Hernandez VH, Morgutti M, Mammano F, et al. (2006) Selective defects in channel permeability associated with Cx32 mutations causing X-linked Charcot-Marie-Tooth disease. Neurobiol Dis 21: 607–617. 23. Ri Y, Ballesteros JA, Abrams CK, Oh S, Verselis VK, et al. (1999) The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophys J 76: 2887–2898. 24. Horovitz A, Serrano L, Avron B, Bycroft M, Fersht AR (1990) Strength and co- operativity of contributions of surface salt bridges to protein stability. J Mol Biol 216: 1031–1044. 25. Hendsch ZS, Tidor B (1994) Do salt bridges stabilize proteins? A continuum electrostatic analysis. Protein Sci 3: 211–226. 26. Oshima A, Doi T, Mitsuoka K, Maeda S, Fujiyoshi Y (2003) Roles of Met-34, Cys-64, and Arg-75 in the assembly of human connexin 26. Implication for key amino acid residues for channel formation and function. J Biol Chem 278: 1807–1816. 27. Chen Y, Deng Y, Bao X, Reuss L, Altenberg GA (2005) Mechanism of the defect in gap-junctional communication by expression of a connexin 26 mutant associated with dominant deafness. FASEB J 19: 1516–1518. 28. Ressot C, Latour P, Blanquet-Grossard F, Sturtz F, Duthel S, et al. (1996) X- linked dominant Charcot-Marie-Tooth neuropathy (CMTX): new mutations in the connexin32 gene. Hum Genet 98: 172–175. 29. Fleishman SJ, Sabag AD, Ophir E, Avraham KB, Ben Tal N (2006) The structural context of disease-causing mutations in gap junctions. J Biol Chem 281: 28958–28963. 30. Rod TH, Radkiewicz JL, Brooks CL III (2003) Correlated motion and the effect of distal mutations in dihydrofolate reductase. Proc Natl Acad Sci U S A 100: 6980–6985. 31. Nelis E, Haites N, Van Broeckhoven C (1999) Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat 13: 11–28. 32. Kelley PM, Harris DJ, Comer BC, Askew JW, Fowler T, et al. (1998) Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 62: 792–799. All-Atoms Connexon Model 33. Beltramello M, Piazza V, Bukauskas FF, Pozzan T, Mammano F (2005) Impaired permeability to Ins(1,4,5)P3 in a mutant connexin underlies recessive hereditary deafness. Nat Cell Biol 7: 63–69. 34. Sansom MS, Bond PJ, Deol SS, Grottesi A, Haider S, et al. (2005) Molecular simulations and lipid-protein interactions: potassium channels and other membrane proteins. Biochem Soc Trans 33: 916–920. 35. Nunn RS, Macke TJ, Olson AJ, Yeager M (2001) Transmembrane alpha-helices in the gap junction membrane channel: systematic search of packing models based on the pair potential function. Microsc Res Tech 52: 344–351. 36. Kovacs JA, Baker KA, Altenberg GA, Abagyan R, Yeager M (2007) Molecular modeling and mutagenesis of gap junction channels. Prog Biophys Mol Biol 94: 15–28. 37. Silander K, Meretoja P, Pihko H, Juvonen V, Issakainen J, et al. (1997) Screening for connexin 32 mutations in Charcot-Marie-Tooth disease families with possible X-linked inheritance. Hum Genet 100: 391–397. 38. Tan CC, Ainsworth PJ, Hahn AF, MacLeod PM (1996) Novel mutations in the connexin 32 gene associated with X-linked Charcot-Marie tooth disease. Hum Mutat 7: 167–171. 39. Richard G, Smith LE, Bailey RA, Itin P, Hohl D, et al. (1998) Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 20: 366–369. 40. Goodenough DA, Goliger JA, Paul DL (1996) Connexins, connexons, and intercellular communication. Annu Rev Biochem 65: 475–502. 41. Carrasquillo MM, Zlotogora J, Barges S, Chakravarti A (1997) Two different connexin 26 mutations in an inbred kindred segregating non-syndromic recessive deafness: implications for genetic studies in isolated populations. Hum Mol Genet 6: 2163–2172. 42. Bruzzone R, Veronesi V, Gomes D, Bicego M, Duval N, et al. (2003) Loss-of- function and residual channel activity of connexin26 mutations associated with non-syndromic deafness. FEBS Lett 533: 79–88. 43. Locke D, Liu J, Harris AL (2005) Lipid rafts prepared by different methods contain different connexin channels, but gap junctions are not lipid rafts. Biochemistry 44: 13027–13042. 44. Rouger H, LeGuern E, Birouk N, Gouider R, Tardieu S, et al. (1997) Charcot- Marie-Tooth disease with intermediate motor nerve conduction velocities: characterization of 14 Cx32 mutations in 35 families. Hum Mutat 10: 443–452. 45. Park HJ, Hahn SH, Chun YM, Park K, Kim HN (2000) Connexin26 mutations associated with nonsyndromic hearing loss. Laryngoscope 110: 1535–1538. 46. Janssen EA, Kemp S, Hensels GW, Sie OG, Die-Smulders CE, et al. (1997) Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Genet 99: 501–505. 47. Abrams CK, Freidin MM, Verselis VK, Bennett MV, Bargiello TA (2001) Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X- linked form of Charcot-Marie-Tooth disease. Brain Res 900: 9–25. 48. Lee SW, Tomasetto C, Paul D, Keyomarsi K, Sager R (1992) Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol 118: 1213–1221. 49. Oh S, Ri Y, Bennett MV, Trexler EB, Verselis VK, et al. (1997) Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot- Marie-Tooth disease. Neuron 19: 927–938. 50. Ressot C, Gomes D, Dautigny A, Pham-Dinh D, Bruzzone R (1998) Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties. J Neurosci 18: 4063–4075. 51. McGregor MJ, Islam SA, Sternberg MJ (1987) Analysis of the relationship between side-chain conformation and secondary structure in globular proteins. J Mol Biol 198: 295–310. 52. Frei K, Szuhai K, Lucas T, Weipoltshammer K, Schofer C, et al. (2002) Connexin 26 mutations in cases of sensorineural deafness in eastern Austria. Eur J Hum Genet 10: 427–432. 53. Zhang Y, Tang W, Ahmad S, Sipp JA, Chen P, et al. (2005) Gap junction- mediated intercellular biochemical coupling in cochlear supporting cells is required for normal cochlear functions. Proc Natl Acad Sci U S A 102: 15201–15206. 54. Common JE, Becker D, Di WL, Leigh IM, O’Toole EA, et al. (2002) Functional studies of human skin disease- and deafness-associated connexin 30 mutations. Biochem Biophys Res Commun 298: 651–656. 55. Nelis E, Simokovic S, Timmerman V, Lofgren A, Backhovens H, et al. (1997) Mutation analysis of the connexin 32 (Cx32) gene in Charcot-Marie-Tooth neuropathy type 1: identification of five new mutations. Hum Mutat 9: 47–52. 56. Zelante L, Gasparini P, Estivill X, Melchionda S, D’Agruma L, et al. (1997) Connexin26 mutations associated with the most common form of non- syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterra- neans. Hum Mol Genet 6: 1605–1609. 57. Murgia A, Orzan E, Polli R, Martella M, Vinanzi C, et al. (1999) Cx26 deafness: mutation analysis and clinical variability. J Med Genet 36: 829–832. 58. Snoeckx RL, Huygen PL, Feldmann D, Marlin S, Denoyelle F, et al. (2005) GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 77: 945–957. 59. Thonnissen E, Rabionet R, Arbones ML, Estivill X, Willecke K, et al. (2002) Human connexin26 (GJB2) deafness mutations affect the function of gap junction channels at different levels of protein expression. Hum Genet 111: 190–197. PLoS ONE | www.plosone.org 10 July 2008 | Volume 3 | Issue 7 | e2614